Find us on:

LDN (Low-Dose Naltrexone) has been clinically proven as a safe and effective treatment for multiple sclerosis. LDN refers to the use of an FDA-approved drug Naltrexone at low doses­. Originally researched as a cancer treatment, LDN was found effective in treating autoimmune diseases such as MS.

Patient Stories

Ready to try LDN?

Browse our directory to find a list of physicians knowledgeable about LDN in your city or state. Or try doctors specializing in telemedicine.

Browse Physician Directory

Understanding MS

Multiple Sclerosis (MS) is the world’s most common autoimmune neurological disease, as over 2.5 million people globally have some form of MS.

Learn about MS

LDN for MS: Clinical Studies

Multiple Sclerosis (MS) is the world’s most common autoimmune neurological disease, as over 2.5 million people globally have some form of MS.

Explore Clinical Studies